Episode Details
Back to Episodes
1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross
Published 8 years ago
Description
We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.